ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples